SprigPilot is a medical cannabis resource intended for adults. Please confirm your age to continue.
By entering you confirm you are of legal age in your jurisdiction. SprigPilot provides information and education, not medical or legal advice.
Federal cannabis law is shifting faster than it has in decades — rescheduling, agency rulemaking, and the federal–state gap are all in motion. This page tracks those developments as they happen, with an eye on what they mean for medical patients. Information, not legal advice.
I don't see an actual news article or content to rewrite in your message. You've provided only a title and a summary heading without the body text. Please share the full article content and I'll create a neutral, 2-sentence summary for you.
The DEA administrative law judge has ordered new reply submissions in the cannabis rescheduling proceeding, which continues to face delays in the federal review process. The case remains stalled as stakeholders await further developments in the regulatory evaluation of cannabis's scheduling classification.
The U.S. Attorney General stated that federal rescheduling of marijuana would not create conflicts with states that have already legalized cannabis. The statement suggests potential alignment between federal policy changes and existing state-level cannabis regulations.
A federal administrative law judge has directed the DEA to respond to a request from marijuana rescheduling opponents seeking additional testimony and documents in the ongoing proceeding. The order requires the agency to address whether new evidence should be allowed in the case examining cannabis's current Schedule I classification.
The proposed rescheduling of marijuana at the federal level has been temporarily suspended pending further regulatory review. The delay allows for additional oversight and assessment before any changes to the drug's current classification are implemented.